0001209191-18-003986.txt : 20180117
0001209191-18-003986.hdr.sgml : 20180117
20180117164610
ACCESSION NUMBER: 0001209191-18-003986
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180116
FILED AS OF DATE: 20180117
DATE AS OF CHANGE: 20180117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALTSHULER DAVID
CENTRAL INDEX KEY: 0001550395
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 18531905
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-16
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001550395
ALTSHULER DAVID
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, Global Research and CSO
Common Stock
2018-01-16
4
S
0
23813
155.77
D
82198
D
Common Stock
2018-01-16
4
S
0
11767
156.63
D
70431
D
Common Stock
2018-01-16
4
S
0
6130
157.71
D
64301
D
Common Stock
2018-01-16
4
S
0
10585
158.82
D
53716
D
Common Stock
2018-01-16
4
S
0
3955
159.41
D
49761
D
Transaction made pursuant to Mr. Altshuler's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $155.77 (range $155.19 to $156.17).
Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $156.63 (range $156.19 to $157.18).
Open market sales reported on this line occurred at a weighted average price of $157.71 (range $157.20 to $158.19).
Open market sales reported on this line occurred at a weighted average price of $158.82 (range $158.21 to $159.20).
Open market sales reported on this line occurred at a weighted average price of $159.41 (range $159.21 to $159.65).
/s/ Omar White, Attorney-in-Fact
2018-01-17